News Carl Icahn planning proxy fight at Illumina; report Activist investor claims takeover of liquid biopsy firm Grail points to "reckless" management.
News Forget Merck, now Pfizer is said to be after Seagen Rumour of negotiations comes as Pfizer is facing a steep patent cliff in the next few years.
News Redx joins with Jounce to create cancer, fibrosis biotech Merger is announced after Jounce said it will slash staff and seek partners for its programmes.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
